State Street’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

State Street’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-79,132	Closed	-$10.3K	–	4823
2023 Q1	$10.3K	Hold	79,132	–	–	﹤0.01%	4738
2022 Q4	$13K	Hold	79,132	–	–	﹤0.01%	4780
2022 Q3	$51K	Hold	79,132	–	–	﹤0.01%	4653
2022 Q2	$192K	Hold	79,132	–	–	﹤0.01%	4217
2022 Q1	$320K	Buy	79,132 +4,192	+6%	+$23K	﹤0.01%	4216
2021 Q4	$600K	Buy	74,940 +400	+0.5%	+$4.69K	﹤0.01%	3953
2021 Q3	$1.44M	Buy	74,540 +3,400	+5%	+$59.4K	﹤0.01%	3700
2021 Q2	$982K	Buy	+71,140	New	+$843K	﹤0.01%	3669

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

State Street's PLXP Position: Q2 2023 in Review

State Street sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 79,132 shares — an estimated $10.3K sold.

State Street first reported a position in PLXP in Q2 2021 and held it in 8 quarters. The position peaked at $1.44M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

State Street reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
State Street sold 79,132 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $10.3K.
State Street first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and held it in 8 quarters.
State Street's PLx Pharma Inc. Common Stock position peaked at $1.44M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.